Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
13.41
-0.24 (-1.76%)
At close: Feb 6, 2026
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $53.15 billion as of February 6, 2026. Its market cap has increased by 140.24% in one year.
Market Cap
53.15B
Enterprise Value
91.57B
Revenue
53.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
$13.41
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 53.15B, an increase of 807.08%. That is a compound annual growth rate of 6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 53.15B | 24.28% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 805.86M |
| Glass House Brands | 756.71M |
| Elite Pharmaceuticals | 481.05M |
| Northwest Biotherapeutics | 406.62M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| CytoDyn | 317.38M |
| OpGen | 310.55M |